申请人:MOCHIDA PHARMACEUTICAL CO., LTD.
公开号:EP1908753A1
公开(公告)日:2008-04-09
A compound represented by formula (I'):
(wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, -NR3-, or -S(O)r-; X2 represents a methylene group, O, -NR3-, or - S(O)r-; Q' represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
式 (I') 所代表的化合物:
(其中 m、n 和 p 分别代表 0 至 2;q 代表 0 或 1;R1 代表卤素、烃基、杂环基、烷氧基、烷氧羰基、氨基磺酰基、CN 基、NO2 基或类似基团;R2 代表卤素、氨基、烃基、芳香杂环基或氧代基团;X1 代表 O、-NR3- 或 -S(O)r- ;X2代表亚甲基、O、-NR3-或-S(O)r-; Q'代表杂芳基、杂芳烷基、取代芳基或芳烷基;循环分子代表芳基环或杂芳环;波浪线代表E-异构体或Z-异构体)、化合物的盐、或化合物或盐的溶液。一种药物组合物和一种瞬时受体电位Ⅰ型(TRPV1)受体拮抗剂各自含有至少一种化合物、化合物的盐和化合物或盐的溶液作为活性成分。